Exosomes, membrane-bound nanosized vesicles of biologic
origin,
are known to contain various molecules, e.g., proteins, lipids, and
nucleic acids, which contribute to the exosomes’ ability to
mediate cell-to-cell communication. Recent impediments of artificial
nanoparticles in drug delivery, including low cellular uptake, activation
of the immune system, and tissue obstacles, have led scientists to
engineer exosomes as drug delivery vehicles. Though exosomes possess
inherent properties of stability, biocompatibility, low immunogenicity,
and capability to cross biological barriers, there is a need to develop
technologies that allow the efficient loading of therapeutic materials
into exosomes. Here, we introduced a simple peptide-equipped technology
that can enhance the cargo-loading potential of exosomes in a mild
loading environment. Specifically, a known cell-penetrating peptide,
YARA, derived from human immunodeficiency virus-1 trans-activator
of transcription, was covalently conjugated with miR-21-5p, a mammalian
microRNA. The conjugate YARA-miR-21-5p was then incubated with exosomes,
isolated from either mesenchymal stem cells or cancer cells, for loading.
Exosomal loading of YARA-miR-21-5p was time-dependent and demonstrated
an impressive 18.6-fold increase in efficiency over exosomal loading
of miR-21-5p through incubation. After effective cellular uptake,
the loaded exosomes rapidly delivered YARA-miR-21-5p into mammalian
cells. Relative to unloaded exosomes and free YARA-miR-21-5p, the
loaded exosomes significantly enhanced the proliferation, migration,
and invasion of human and mouse fibroblasts, which are vital steps
in wound healing. This study lays the groundwork for using cell-penetrating
peptides as an innovative approach to efficiently load therapeutic
cargos, e.g., microRNAs, into exosomes, which can then be employed
to deliver the cargos into cells to yield biological effects.